• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALCON RESEARCH, LTD. - HUNTINGTON MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE C; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALCON RESEARCH, LTD. - HUNTINGTON MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE C; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Catalog Number 8065977762
Device Problem Break (1069)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/24/2017
Event Type  Injury  
Manufacturer Narrative
Product evaluation: the product was not returned for analysis.Cartridge product history records were reviewed and documentation indicates the product met release criteria.There have been no other complaints reported in the lot number.The iol product history record could not be reviewed because facility did not provide a lot number or any identification traceable to the manufacturing documentation.A root cause has not been identified.(b)(4).
 
Event Description
A physician reported that during the lens implantation portion of a cataract removal with intraocular lens (iol) implant procedure, the cartridge broke, and the iol "shot out", leading to a posterior capsule defect.The procedure was able to be completed successfully.The health and sight of the patient was not impaired; the event reportedly resolved with treatment.Additional information has been requested.
 
Manufacturer Narrative
The facility indicated the use of a 33.0 diopter iol.The highest qualified diopter range for the reported cartridge is 30.0.The most likely root cause is a failure to follow the directions for use (dfu).The cartridges are qualified with iols for specific diopter ranges.A 33.0 diopter iol is not qualified for use with the reported cartridge.The use of non-qualified product combination may lead to damage and/or delivery issues.The following information was also provided: after a small training on "which cartridge is suitable for which lens/diopter" the team (of the hospital/initial reporter) considers this issue as completed.They used cartridges that were too small for higher lens strengths, but are now satisfied with the correctly ordered cartridges.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MONARCH III IOL DELIVERY SYSTEM, CARTRIDGE C
Type of Device
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
ALCON RESEARCH, LTD. - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer (Section G)
ALCON RESEARCH, LTD. - HUNTINGTON
6065 kyle lane
huntington WV 25702
Manufacturer Contact
nadia bailey
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8176152230
MDR Report Key7135888
MDR Text Key95447351
Report Number1119421-2017-01446
Device Sequence Number1
Product Code MSS
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
K112977
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/20/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date05/31/2022
Device Catalogue Number8065977762
Device Lot Number32553736
Other Device ID Number00380659777622
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/06/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/20/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-